Patents by Inventor Anthony Pinkerton

Anthony Pinkerton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070049591
    Abstract: The present invention relates to compounds useful as inhibitors of MEK kinase and methods for the treatment or prevention of cellular proliferative disease states, such as conditions related to the hyperactivity of MEK, as well as diseases modulated by the MEK cascade.
    Type: Application
    Filed: August 24, 2006
    Publication date: March 1, 2007
    Inventors: Anthony Pinkerton, Robert Davis, Timothy Gahman, J. Semple
  • Publication number: 20050288346
    Abstract: The present invention is directed to compounds which are potentiators of metabotropic glutamate receptors, including the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved.
    Type: Application
    Filed: August 22, 2003
    Publication date: December 29, 2005
    Inventors: Rowena Cube, Anthony Pinkerton, Jean-Michel Vernier, Xiumin Zhao